Cáncer microcítico de pulmón

  1. Navarro Expósito, Fátima
  2. López González, José Luis
  3. Molina Villaverde, Raquel
  4. Álvarez de Mon Soto, Melchor
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Ano de publicación: 2013

Título do exemplar: Enfermedades oncológicas (I): cáncer de pulmón y torácico, cabeza y cuello, sistema nervioso central

Serie: 11

Número: 24

Páxinas: 1441-1446

Tipo: Artigo

DOI: 10.1016/S0304-5412(13)70497-9 DIALNET GOOGLE SCHOLAR

Outras publicacións en: Medicine: Programa de Formación Médica Continuada Acreditado

Resumo

Small cell lung cancer is a rapid growing neoplasm with good initial response to chemotherapy treatment. However, the response is generally short-lived. In limited stage, the treatment of choice is a combination of cisplatin and etoposide, together with radiotherapy concomitantly. Response rate is high and a significant percentage of long survivals can be achieved. However, in disseminated stage, and despite the chemotherapy, global survival is very short, the patients hardly surviving more than 2 years. In spite of the development of many new drugs in Oncology, few of them have been promising in this cancer.